Prostate Adenocarcinoma: Mutation Analysis (MutSig vS2N)
Maintained by Dan DiCara (Broad Institute)
- Overview
+ Introduction
- Summary
- Results
- Significantly Mutated Genes

Column Descriptions:

  • N = number of sequenced bases in this gene across the individual set

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • nnull = number of (nonsilent) null mutations in this gene across the individual set

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 8. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene N nflank nsil nnon nnull p q
NKX3-1 4482 0 0 5 1 6e-52 1.1e-47
ZMYM3 29005 0 0 5 3 1.9e-18 1.8e-14
TP53 10458 0 0 5 1 3.5e-12 2.2e-08
MLL3 134697 2 0 10 7 2.7e-11 1.3e-07
SPOP 11452 2 0 4 0 3.7e-07 0.0014
MUC4 53171 0 2 5 0 1e-06 0.0033
ATM 99612 0 0 5 0 6.8e-06 0.018
CNTNAP5 34965 0 0 5 1 0.000039 0.091
TTN 1059218 1 4 18 4 0.002 1
YBX1 6723 0 0 4 0 0.0021 1
AHNAK2 141681 0 2 7 0 0.0074 1
FRG1 8715 1 0 4 1 0.0085 1
PRR21 5229 0 0 4 0 0.099 1
LRP1B 143560 2 1 5 1 0.19 1
MUC16 382810 1 4 9 0 0.21 1
FCGBP 80613 0 1 5 0 0.25 1
TPTE2 18418 1 0 4 1 0.29 1
LPHN3 35599 0 1 4 0 0.35 1
MUC17 112710 0 1 5 0 0.36 1
INADL 52620 3 0 4 1 0.39 1
RP1 67724 0 0 4 1 0.39 1
FAT1 134152 0 1 5 0 0.42 1
SYNE1 272080 6 1 5 0 0.47 1
HSPG2 87788 0 1 4 0 0.53 1
GRID2 30955 0 1 4 0 0.54 1
ASH1L 87644 1 0 4 2 0.58 1
SETD5 35360 0 1 4 0 0.58 1
DMXL2 90047 1 0 4 3 0.58 1
CSMD3 110953 2 1 4 2 0.81 1
FZD2 14278 0 4 4 1 0.84 1
FAT4 142381 0 3 4 1 0.85 1
CROCC 24473 7 1 4 0 0.92 1
AGT 13114 0 0 3 0 1 1
AIM2 11618 0 0 3 1 1 1
ANK2 110058 2 0 3 0 1 1
+ Methods & Data